Cell nuclei

Landmark discovery: H2AX as a sensor of DNA damage

Jul 16, 2019

William Bonner’s curiosity about histones led to the discovery that the protein H2AX is altered in response to harmful DNA damage called a double-strand break. This powerful tool has led to breakthroughs in both basic and clinical cancer research.  Read more...

Landmark discovery: H2AX as a sensor of DNA damage
rhabdosarcoma cells

Sarcoma Awareness Month

Jul 1, 2019

July is Sarcoma Awareness Month and we are highlighting our researchers who are advancing research discovery in this field. Read more...

Immunotherapy depicted with a cell

June is Cancer Immunotherapy Awareness Month

Jun 5, 2019

To celebrate Cancer Immunotherapy Month this June, we are highlighting our researchers who have helped pioneer this research and continue to make seminal advances in this growing field.  Read more...

June is Cancer Immunotherapy Awareness Month
Anaisa Quintanilla-Arteaga in the lab

iCURE helps a first-generation American reach her goal

May 6, 2019

Anaisa Quintanilla-Arteaga’s ultimate goal is to be the Latina scientist she wishes she had seen when she was younger, and “hopefully help younger generations of Latinas realize that they belong and can thrive in STEM, too.” An iCURE fellowship is helping her achieve that dream. Read more...

Megan Andres

Undergraduate Research Scholar Program fellow continues her pursuit of science

Apr 25, 2019

Megan Andres is an NIH Undergraduate Scholarship Program (UGSP) fellow with Beverly Mock, Ph.D., Deputy Chief of the Laboratory of Cancer Biology and Genetics. The UGSP program offers competitive scholarships to students from disadvantaged backgrounds who are committed to careers in biomedical, behavioral and social science health-related research. She is hoping to make a difference in possible treatment options for children with Burkitt lymphoma. Read more...

Rania Labib

African Postdoctoral Training Initiative fellow looks forward to collaborating within NCI

Apr 18, 2019

Rania Labib, Ph.D., is a postdoctoral fellow in the NIH African Postdoctoral Training Initiative (APTI) working in the lab of Beverly Mock, Ph.D., Deputy Chief of the Laboratory of Cancer Biology and Genetics. As part of the fellowship, she will spend two years at NCI conducting initial experiments in Dr. Mock’s lab, where she hopes to make a difference in possible treatment options for children with Burkitt’s lymphoma.  Read more...

Felicia Knaul, Ph.D.

Recap: Grand Rounds with Felicia Knaul, Ph.D.

Feb 19, 2019

Nearly 200 CCR staff attended a special Grand Rounds lecture this month featuring Felicia Knaul, Ph.D., an expert in palliative care. Dr. Knaul, a professor at the Leonard M. Miller School of Medicine and Director of the University of Miami Institute for Advanced Study of the Americas, discussed the unequal access to pain and palliative care around the world, particularly related to morphine for pain relief, and the critical importance of educating providers.The lecture, held February 1, was sponsored by CCR’s Women Scientist Advisors (WSAs).   Read more...

Neuro-Oncology Branch

Watch new Neuro-Oncology Branch video on NCI YouTube

Jan 10, 2019

The Neuro-Oncology Branch is comprised of an exceptional team of experts across scientific disciplines and medical specialties dedicated to developing new treatments for patients with brain and spine cancers using the latest technologies. Learn more about this department. Read more...

Watch new Neuro-Oncology Branch video on NCI YouTube
Best places to work

Glassdoor recognizes NIH as one of the best places to work

Dec 31, 2018

NIH has been recognized as one of the best places to work by Glassdoor and the Partnership for Public Service. Glassdoor rankings were “determined by the people who know these companies best - their employees.” The Partnership for Public Service rankings were determined by the views of more than 847,000 civil servants from 488 federal organizations on a wide range of workplace topics. Read more...

Glassdoor recognizes NIH as one of the best places to work
NCI connect

View the new NCI-CONNECT video on YouTube

Dec 27, 2018

NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous system (CNS) cancers by establishing and fostering patient-advocacy-provider partnerships and networks to improve approaches to care and treatment. Learn more about NCI-CONNECT through this new video. Read more...

View the new NCI-CONNECT video on YouTube

Pages